Jamie Graham is currently Associate Director and Senior Patent Counsel at Boehringer Ingelheim USA. Prior to joining Boehringer, Jamie practiced patent law for 30 years at Kilpatrick Townsend, many of them as a partner. At...more
In earlier posts, we reported that the Supreme Court granted Minerva Surgical, Inc.’s petition for a writ of certiorari on the question of “whether a defendant in a patent infringement action who assigned the patent, or is in...more
In this episode, Cecilia Andrews, Director of Intellectual Property for Novelis, Inc., shares her approach to building an authentic brand and delivering high-impact value for clients and colleagues. Cecilia relates her career...more
Huong Nguyen is currently Vice President, General Counsel, of Fosun Pharma USA Inc. She has spent the majority of her nearly two-decade law practice actively working in the pharmaceutical industry as both an in-house counsel...more
Drug pricing and innovation are hot topics in Washington right now with several bills making their way through the legislative process, many in a bipartisan fashion. On April 23, 2021, two of these bills were signed into law...more
In this episode, April and Kim interview Mary Hannon, the woman who started the public conversation about the gender gap in the patent bar and inspired this podcast. Mary is currently a law student at DePaul University and in...more
5/14/2021
/ Bar Exam ,
Bias ,
Career Development ,
Eligibility ,
Gender Discrimination ,
Intellectual Property Litigation ,
Patent Litigation ,
Patents ,
Trial Attorneys ,
USPTO ,
Women in the Law
Background -
The patent statute recognizes that an invention may be jointly invented, however, there is no definition of inventorship in the patent statute. For this reason, the courts have been left to determine what...more
As previously reported on March 31, 2021, AbbVie Inc. has petitioned the U.S. Supreme Court for a writ of certiorari to review the Third Circuit’s ruling determining the biopharma company’s patent infringement suit was a sham...more
April Abele Isaacson has 25 years of experience as a trial lawyer and a registered United States patent attorney. Before starting her legal career, April earned a MS in Pharmacological and Physiological Sciences and was an...more
As previously reported on March 17, 2021, the Federal Circuit affirmed the Patent Trial and Appeal Board (PTAB) decision that the rejected claims of a patent application owned by The Board of Trustees of Leland Stanford...more
Kim Davis is a rising star in the patent bar. Kim earned a Ph.D. in organic chemistry from Emory University and her scientific training is instrumental in her practice, which focuses on prosecuting foreign and domestic patent...more
As previously reported, in January 2021, the Supreme Court granted a petition for a writ of certiorari filed by Minerva Surgical, Inc. on the question of “whether a defendant in a patent infringement action who assigned the...more
On March 11, 2021, in an Opinion by Judge Reyna, along with Chief Judge Prost and Judge Lourie, the Federal Circuit affirmed the Patent Trial and Appeal Board (PTAB) decision that the rejected claims of a patent application...more
On March 5, 2021, bipartisan members of the Senate Committee on the Judiciary Subcommittee on Intellectual Property, Senators Tillis (R-NC), Hirono (D-HI), Cotton (R-AR) and Coons (D-DE), sent a letter to the USPTO’s...more
Why does a gaping gender gap persist in the patent bar and what’s to be done about it? In this inaugural episode of Sidebars, a limited-series podcast for women in patent law, Kilpatrick Townsend partners April Abele Isaacson...more
We're pleased to introduce Sidebars! This limited podcast series by Kilpatrick Townsend's biopharma team showcases today's leading women in the patent bar. Each of the episodes is a candid conversation between groundbreaking...more
Approval Processes -
The regulatory approval pathway for a new “biological product” submitted as a Biologics License Application (BLA) under the Biologics Price Competition and Innovation Act (BPCIA), is now separate from...more
On January 13, we originally posted on this topic. An update was posted on February 5. This post provides the most recent update on this matter.
Yesterday, the Federal Circuit granted Teva’s petition for en banc rehearing....more
The U.S. House of Representatives generated buzz in November 2020 when it passed a bill aimed at removing a loophole in the Orphan Drug Act. Although the bill did not make it far in the Senate, the bipartisan legislative push...more
On January 8, 2021, the Supreme Court granted a petition for a writ of certiorari filed by Minerva Surgical, Inc. on September 30, 2020. The question presented is “whether a defendant in a patent infringement action who...more
Statutory Basis For Label Carve-Outs -
Section viii of the Hatch-Waxman Act permits an Abbreviated New Drug Application (ANDA) applicant to obtain FDA approval to market a generic version of a drug for a non-patented use...more
For several years, China has been evaluating changes to its drug approval system to promote drug innovation and patient access to medicines. The year 2020 saw China begin taking steps towards adopting some of those changes....more